首页 >
法规速递
-
Submitting Continuous Glucose Monitoring Data in Clinical Trials-2026/5/6
2026-05-08查看详情 > -
国家药监局药审中心发布《中国新药注册临床试验进展年度报告（2025年）》-2026/6/22
2026-06-22查看详情 > -
Guideline on core SmPC, labelling and package leaflet for advanced therapy medicinal products (ATMPs) containing genetically modified cells (updated)-2022/10/26
2022-11-15查看详情 > -
国家药监局关于改革完善放射性药品审评审批管理体系的意见 国药监药注〔2023〕20号-2023/4/25
2023-04-26查看详情 > -
关于公开征求《中药制剂稳定性研究技术指导原则（征求意见稿）》意见的通知-2023/10/30
2023-11-06查看详情 > -
Document: Outcome of Public consultation on Policy 0044 - Summary of comments and EMA feedback-2025/1/14
2025-01-15查看详情 > -
Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure-2025/2/18
2025-02-19查看详情 > -
Document: Annual report of the Good Manufacturing and Distribution Practice Inspectors Working Group 2024-2025/3/27
2025-03-28查看详情 > -
Document: Policy 58: European Medicines Agency policy on the handling of competing interests of Management Board members-2025/5/1
2025-05-06查看详情 > -
Document: Agenda - Workshop on the use of Bayesian statistics in clinical development-2025/6/12
2025-06-13查看详情 >
